Loading clinical trials...
Loading clinical trials...
Evaluation of the Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players Occurring Over One Training Season
The main objective of this study is to estimate the incidence and prevalence of Internal Rotation Deficit (IRD) defined by a measure of IRD 2 (Internal Rotation Deficit in position 2) strictly greater than 20 ° in a population of advanced-level handball players over a training season.
The secondary objectives of this study are : A- To estimate and compare the prevalence of Internal Rotation Deficit within groups B- To assess the association between the Internal Rotation Deficit and the appearance of a shoulder pain and/or discomfort when throwing C- To assess the association between Internal Rotation Deficit and the appearance of a shoulder pathology demonstrated by clinical examination by at least one abnormality in one of the following three tests: the arming apprehension test, the relocation test or the O'Brien test D- Assess changes in values of IRD 2, the ratio IRD 2/GRE 2, and the Total Range of Motion over the training season E- Evaluate the association between the values of IRD 2 and the appearance of shoulder pain or discomfort when throwing F- To evaluate the association between IRD 2 values and the appearance of a shoulder pathology (at least one anomaly in one of three tests: the arming apprehension test, the relocation test or the O'Brien test). G- To assess the association between values of the IRD 2/GRE 2 ratio and the appearance of shoulder pain or discomfort when throwing H- To assess the association between values of the IRD 2/GRE 2 ratio and the appearance of a shoulder pathology (at least one anomaly in one of three tests: the arming apprehension test, the relocation test or the O'Brien test). I- To estimate the optimal threshold value of the IRD 2/GRE 2 ratio that would define an Internal Rotation Deficit in a more relevant fashion as compred to the IRD 2 alone
Age
All ages
Sex
ALL
Healthy Volunteers
No
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, France
Start Date
January 1, 2014
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2014
Last Updated
March 26, 2015
86
ACTUAL participants
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
NCT07201597
NCT06153121
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07016243